Nutley, NJ, 25 July 2023 – Modern Meadow, a purpose-driven biotechnology company, announces the next chapter of its growth having raised Series D funding.

For the past decade, Modern Meadow’s investment in research and development across material science and biotechnology has paved the way for a future of biobased, sustainable consumer products. 

Led by Astanor Ventures, Horizons Ventures and Key Partners Capital, the Series D supports Modern Meadow to continue its innovation as a leader in biofabrication.

With the closing of the Series D, Modern Meadow is poised to deliver on its mission to lead a material revolution in bringing environmentally responsible products to market.

For more information on Modern Meadow, please contact Jason Bailey at jbailey@modernmeadow.com.